A detailed history of Vontobel Holding Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 24,574 shares of ALKS stock, worth $676,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,574
Previous 20,119 22.14%
Holding current value
$676,522
Previous $544,000 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$23.21 - $27.24 $103,400 - $121,354
4,455 Added 22.14%
24,574 $592,000
Q1 2024

May 10, 2024

BUY
$26.4 - $32.56 $531,141 - $655,074
20,119 New
20,119 $544,000
Q1 2023

Jun 03, 2024

SELL
$25.31 - $29.02 $321,917 - $369,105
-12,719 Reduced 63.22%
7,400 $208,000
Q1 2023

Apr 12, 2023

SELL
$25.31 - $29.02 $64,413 - $73,855
-2,545 Reduced 25.59%
7,400 $208,000
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $218,193 - $260,956
9,945 New
9,945 $259,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.52B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.